CHINOOK THERAPEUTICS KDNY 深 沪
交易中 07-07 11:40:06 美东时间
40.39
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 40.39
- 总市值 290.02万
- 52周最高 40.51
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 18.34
- 委 比 0.00%
- 总股本 7.18万
- 历史最高 246.25
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.505
- 每 手 1
- 风险率 0.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tango Therapeutics Appoints Robert Azelby to Board of Directors
Tango Therapeutics appoints Robert Azelby to its Board of Directors. With over 30 years of biopharmaceutical leadership, Azelby brings expertise in oncology commercialization and corporate strategy. His addition coincides with the advancement of vopimetostat, a potential PRMT5 inhibitor for pancreatic cancer, toward late-stage development. Azelby's experience will support Tango's mission to transform care for patients with MTAP-deleted cancers.
06-22 20:05
Rigetti Computing Signs New Berkeley Lab Space Sublease
Rigetti Computing ( ($RGTI) ) has shared an announcement. On April 17, 2026, Ri...
04-22 04:42
单日暴涨130%+，肾病领域再成行业焦点
转自：新康界 4月30日，诺华公司宣布以17亿美元收购美股上市医药公司Regulus(NASDAQ:RGLS)，受此消息影响，Regulus的股价...
2025-06-23 19:50
UPDATE 3-Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
Updates shares, adds analyst comment in paragraph 6 By Bhanvi Satija and Mariam Sunny April 30 (Reuters) - Novartis NOVN.S has agreed to buy Regulus Therapeutics RGLS.O for up to $1.7 billion, giving ...
2025-04-30 19:30
